filmov
tv
Bivalent boosters for kids, long COVID study, monkeypox decline & more with Andrea Garcia, JD, MPH
Показать описание
AMA's Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares details of the FDA's authorization for COVID boosters for kids 5 to 11, early Pfizer data on the bivalent booster and a study on long COVID, plus the latest on monkeypox and Ebola. American Medical Association CXO Todd Unger hosts.
0:00 AMA Update for Oct. 17, 2022
0:27 FDA authorization of new bivalent COVID boosters for younger children 5 to 11.
1:40 Why is the COVID booster important?
2:18 New Pfizer data on the COVID booster
3:57 How are COVID cases trending?
4:23 How are COVID hospitalizations and deaths trending?
5:11 Long COVID study out of Scotland
6:25 Long COVID symptoms
7:17 How many people have long COVID in the U.S.?
7:56 Monkeypox trends
9:40 Ebola outbreak in Uganda
10:18 Vaccinations for Ebola
0:00 AMA Update for Oct. 17, 2022
0:27 FDA authorization of new bivalent COVID boosters for younger children 5 to 11.
1:40 Why is the COVID booster important?
2:18 New Pfizer data on the COVID booster
3:57 How are COVID cases trending?
4:23 How are COVID hospitalizations and deaths trending?
5:11 Long COVID study out of Scotland
6:25 Long COVID symptoms
7:17 How many people have long COVID in the U.S.?
7:56 Monkeypox trends
9:40 Ebola outbreak in Uganda
10:18 Vaccinations for Ebola